Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLETS OF NATEGLINIDE

Raksha Malviya1, Gurdeep Singh*2, Gulfisha Shaikh1

1Department of Pharmaceutics, Oriental College of Pharmacy & Research, Oriental University, Indore (M.P.)

2Department of Pharmaceutical Chemistry, Oriental College of Pharmacy & Research, Oriental University, Indore (M.P.)

ABSTRACT

The study was carried to formulate and evaluate dispersible tablet dosage form obtaining Nateglinide. Nateglinide is a drug for the treatment of type 2 diabetes. The present study is an attempt to select best possible combination of diluents and disintegrates to formulate fast dissolving tablets of Nateglinide which disintegrates within few minutes thereby reducing the time of onset of action. A combination of super disintegrants, i.e., sodium starch glycolate (SSG) and croscarmellose sodium (CCS) were used. IR spectroscopy showed that there is no interaction of the drug with the polymer. Direct Compression method was used to formulate the tablets. All the formulations were showed the acceptable flow properties and the pre-compression parameters like Bulk density, Tapped density and Hausner ratio. The post compression parameters like Hardness, Friability, Disintegration time, Weight variation, wetting time, Dispersion time values were found to be within the IP limits. The percentage Drug content of all tablets was found to be between 97.30% - 99.23 % of Nateglinide, which is within the limit. From the results it was found that the F6 batch was found to be optimized batch and it pass all the pre-formulation parameters and evaluation results as per the IP limits.

Keywords: Nateglinide, Type 2 diabetes, wetting time, Hausner ratio, Tapped density.


[Full Text Article]